The Lancet Infectious Diseases
Издатель: Elsevier · ISSN 1473-3099 · 79 статей
-
Merck's alimatravir licensing deal receives mixed response
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Ed Holt
-
WHO updates guidelines for visceral leishmaniasis
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Sanjeet Bagcchi
-
The Global Fund supports malaria response in DR Congo
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Manjulika Das
-
Infection prevention and control gaps in Pakistan
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Talha Burki
-
Bruce Ribner
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Udani Samarasekera
-
Sneeze: The History and Science of the Common Cold, David Miles. August Books (2026), 352, £10·99, 13, ISBN: 978-1-804-36924-1
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Emma Fabiani
-
The Silent Killer: The Untold Story of Humanity's Deadliest Infection and the Fight to Eradicate It, Liora Ashfield. independently published (2026), 104, £15·78, ISBN: 9798254726913
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Sanjeet Bagcchi
-
Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Avina Vongpradith, Regina-Mae Villanueva Dominguez, Lorainne Tudor Car, Amanda Movo, Samuel M Ostroff, Jiawei He, Samuel B Albertson,...
-
Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trial
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Rodney Dawson, Andreas H Diacon, Ebrahim Variava, Tumelo Moloantoa, William Brumskine, Tlhago Ngwanto, Ntokozo Zuma-Gwala, Ayman...
-
Effectiveness of oral care for the prevention of non-ventilator hospital-acquired pneumonia (HAPPEN): a multicentre, stepped-wedge, cluster-randomised trial in Australia
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Nicole M White, Philip L Russo, Georgia Matterson, Katrina Browne, Allen C Cheng, Martin Kiernan, Peta E Tehan, Andrew J Stewardson,...
-
Effect of a community-based behavioural intervention bundle to improve antibiotic use and patient management in Burkina Faso and DR Congo (CABU-EICO): a cluster-randomised controlled trial
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Brecht Ingelbeen, Daniel Valia, Bijou Mbangi, Esther van Kleef, Linda Campbell, Juste Stéphane Kouanda, César-Augustin Mambuku Khoso...
-
Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trial
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Frank Bähner, Saul N Faust, Leela R L Davies, Olga Blokhina, Donald M Brandon, William B Smith, Vengalil Krishna K Chatterjee, Hana...
-
Improving the treatment of invasive fungal infections: novel antifungal and host-directed therapies
Publication date: Available online 18 November 2026 Source: The Lancet Infectious Diseases Author(s): Simon Feys, Rosanne Sprute, Sarah Dellière, Dimitrios Kontoyiannis, Katrien Lagrou, Bart J A Rijnders, Isabel Spriet, George R...
-
Thelazia callipaeda: an emerging zoonotic eyeworm from Asia to Europe and North America
Publication date: Available online 18 November 2026 Source: The Lancet Infectious Diseases Author(s): Domenico Otranto, Alicia Rojas, Marcos Antonio Bezerra-Santos, Jairo Alfonso Mendoza-Roldan, Filipe Dantas-Torres
-
Neutralising antibody responses to MPXV clades Ia, Ib, and IIb after infection or vaccination: a multicountry observational study
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Jameson Crandell, Raianna F Fantin, Leonardo Pereira de Araújo, Lauren Lawres, Lauren Pischel, Valter S Monteiro, Luciana Conde,...
-
Yellow fever vaccination in healthy Gambian children of different ages to establish safety and immunogenicity of a booster dose: a open-label, non-randomised, single-site, phase 3 vaccine trial
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Caitlin Pley, David J Jeffries, Ebrima Kanteh, Julia Strandmark, Aru Kumba Baldeh, Mam Nabou Leigh, Peter Ndow, Ed Clarke, Beate Kampmann
-
Use of tocilizumab for severe hantavirus pulmonary syndrome: a MEURI case series with contextual comparisons
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Fernando Tortosa, Germán Santamaría, Rodrigo Bustamante, Martín Alberto Ragusa, Ayelén Iglesias, Yesica Espasandin, Ariel Izcovich
-
Expert consensus on case definitions in human loiasis: a Delphi study
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Luzia Veletzky, Spinello Antinori, Sabine Bélard, Marielle Bouyou, Emmanuel Bottieau, Jérémy T Campillo, Cédric B Chesnais, Fernando...
-
Therapeutic plasma exchange and continuous renal replacement therapy for severe dengue with multiorgan failure: a case report and focused review
Publication date: Available online 17 November 2026 Source: The Lancet Infectious Diseases Author(s): Alexandre Mestre Tejo, Maysa Sales dos Santos, Pedro Fortes Osório Bustamante, Flávia Vanessa Carvalho Sousa Esteves, Felipe Medauar...
-
A systematic review of Nipah virus disease epidemiological parameters, outbreaks, and mathematical models
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Tristan Naidoo, Christian Morgenstern, Patrick Doohan, Rhys Earl, Thomas Rawson, Richard J Sheppard, Joseph T Hicks, Sreejith...
-
Understanding and exploiting superspreading to disrupt Mycobacterium tuberculosis transmission
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Tyler S Brown, Kristin Nelson, Stephen Kissler, Leo Martinez, C Robert Horsburgh, Laura F White, Barun Mathema, Karen R Jacobson
-
Calciphylaxis complicated by NDM-1-producing Pseudomonas aeruginosa: first experience with cefepime–zidebactam alongside phage therapy in the USA
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Erlinda R Ulloa, Daniel Jaffurs, M Tuan Tran, Carol Lin, Hung Tran, Dorian Chan, Ali Nael, Sagar U Nigwekar, Mikeljon P Nikolich,...
-
Lymphoma-like endoscopic appearance of lymphogranuloma venereum
Publication date: October 2026 Source: The Lancet Infectious Diseases, Volume 26, Issue 10 Author(s): Takumi Wada, Mariko Kobayashi, Kiichiro Tsuchiya
-
Evidence of artemisinin partial resistance in Zambia: a molecular epidemiology and clinical study
Publication date: Available online 7 October 2026 Source: The Lancet Infectious Diseases Author(s): Mulenga Mwenda, Rafael Oliveira, Brenda Mambwe, Carol Chiyesu, Bernd Bohmeier, Karolina Mosler, Miller Phiri, Andy Sinyoolo, Virginia...
-
When the fungus is susceptible, but the patient is not: reading antifungal susceptibility from bench to bedside
Publication date: Available online 8 October 2026 Source: The Lancet Infectious Diseases Author(s): Cornelia Lass-Flörl, Roya Vahedi-Shahandashti
-
Efficacy, safety, and immunogenicity of a nine-valent vaccine (ExPEC9V) for the prevention of invasive Escherichia coli disease in older adults: a phase 3, randomised, placebo-controlled trial (E.mbrace)
Publication date: Available online 12 October 2026 Source: The Lancet Infectious Diseases Author(s): Marc Bonten, Christopher C Butler, Andrew Edwards, Stefan Gravenstein, Hiroshi Ikeda, Isik Somuncu Johansen, Merel M C Lambregts,...
-
Second-season observations after prophylaxis in the evaluation of the impact of nirsevimab in Galicia (NIRSE-GAL) study: mechanistic interpretation and implications for respiratory syncytial virus prevention strategy
Publication date: Available online 13 October 2026 Source: The Lancet Infectious Diseases Author(s): Federico Martinón-Torres, Josefina L Razzini, Iago Giné-Vázquez, Adam Finn
-
Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination
Publication date: Available online 13 October 2026 Source: The Lancet Infectious Diseases Author(s): Leonie Mayer, Rolanda Londt, Eva Gruener, My Linh Ly, Marylyn M Addo, Christof Geldmacher
-
Daptomycin for enterococcal bloodstream infections and endocarditis: reconciling clinical evidence, susceptibility testing, and regulatory frameworks
Publication date: Available online 13 October 2026 Source: The Lancet Infectious Diseases Author(s): Alejandro Díez-Vidal, Pilar Vizcarra, Carlos M Oñoro-López, Cristina Marcelo-Calvo, Alejandro de Gea Grela, Beatriz Díaz-Pollán, Julio...
-
Putting emotion back into pandemic numbers
Publication date: Available online 14 October 2026 Source: The Lancet Infectious Diseases Author(s): Vijay Shankar Balakrishnan